Murali Aravamudan is a serial entrepreneur, inventor and engineer who built successful technology companies in the Media and Telecom ecosystems. Murali is currently focused on his Life Sciences startup nference and affiliate ventures Anumana, Pramana and Vimana.

Powered by its Artificial Intelligence software platform, the nference mission is to transform Healthcare by making biomedical knowledge computable. nference has established novel strategic and exclusive partnerships with multiple Academic Medical Centers including the Mayo Clinic, Duke Health and others to synthesize the holistic institutional knowledge (from 40 million patient lives with longitudinal data) across all structured (complete Electronic Health Record) and unstructured data modalities (ECG/Echo/CT/MRI, Pathology and deep molecular sequencing) using Deep Learning Neural Networks. The nference platform and its massive biomedical corpus is used by several Top Pharma/Biotech, Medical Devices and Diagnostics companies (in addition to the nference affiliates) to accelerate the conception, design, development, life cycle management of Diagnostics and Therapeutics. The company has raised around $150M in venture capital from Matrix Capital Management, NTTVC, Matrix Partners along with strategic investment from Mayo Clinic and Duke Health.

Anumana unlocks the potential of electrophysiological data to transform cardiac care with cutting-edge AI solutions (ECG-AI) for early and efficient diagnosis and treatment. ECG-AI enables a future where ECGs (electrocardiograms) are routinely run through a panel of sophisticated AI algorithms and can perform risk detection across major disease areas.  Four of these algorithms have obtained the FDA Breakthrough Device Designation. In the interventional setting, synthesizing insights using in-procedure Electrogram (EGM data), Anumana AI algorithms democratize Electrophysiology procedures such as Catheter Ablation for Atrial Fibrillation/Ventricular Tachycardia. The company has raised around $86M in venture capital from Matrix Capital Management, Mayo Clinic, and NTTVC.

Pramana is focused on accelerating the digital transformation of Anatomic Pathology. Pramana is revolutionizing digital pathology through the use of a software-first approach to whole slide imaging, leveraging our own robotic slide scanning platform, AI, edge computing and autonomous, dynamic, pixel level z-stacking for unparalleled image quality and data. Pramana’s robotic systems are on pace to create the planet’s largest digital pathology archives by 2024. The company has raised around $30M in venture capital from Matrix Capital Management and NTTVC.

Murali serves on the Board of Directors as well as the Chief Executive Officer of nference, Pramana, and Vimana. He is also the Executive Chairman of the Board of Directors at Anumana.

Previously Murali co-founded Veveo with the goal of enabling quick and efficient content discovery in input constrained devices such as televisions and mobile phones. As CEO of Veveo, he established the company’s leadership in its target market segments with more than 100 million device deployments, and its innovation of conversational interfaces. The thought leadership has translated into an expanding patent portfolio for Veveo with 95 granted US patents and 70+ pending patent applications. Murali helped to raise $28M in equity over two rounds from Matrix Partners, Norwest Ventures and Northbridge Ventures. Veveo was subsequently acquired by Tivo (formerly, Rovi) in 2014 for over $75M.

Prior to founding Veveo in 2005, Murali was vice president and general manager of the Winphoria Division of Motorola’s Global Telecom Solutions Sector, following the successful acquisition of Winphoria Networks, a company he founded in 2000 and led as CTO until its acquisition in 2003.  Winphoria Networks was a pioneer in the groundbreaking Mobile Wireless SoftSwitch and Instant Communications applications for mobile networks. As part of Winphoria, Murali helped to raise $54M in equity over two rounds from Matrix Partners, Norwest Ventures and Northbridge Ventures. Winphoria was subsequently acquired by Motorola for around $200M.

Earlier in his career, Murali served as Vice President and Chief Technology Officer of the Communications Software Business at Lucent Technologies and as a department head of Communications Software Research at Bell Laboratories, Murray Hill. Murali was one of the principals involved in the creation of the SoftSwitch, revolutionary technology for IP-based telephone networks that now serves as the foundation for next-generation converged voice and data networks.

Murali has authored 130 US patents and has more than 100+ pending patents and academic publications in the areas of search, personalization, conversational interfaces, machine learning/AI systems, data networking, telephony and, most recently, computational biology and biomedicine.

Murali holds a Masters degree in Electrical Communication Engineering from Indian Institute of Science, Bengaluru (1989).